{"entity":{"type":"insider","cik":"0001712069","url":"/insider/0001712069","json_url":"/insider/0001712069.json","name":"Lang Matthew","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":20,"first":"2019-12-30","last":"2023-01-20","span_basis":"filed_date"},"name_variants":[{"name":"Lang Matthew","source":"filing","n_filings":20,"first_seen":"2019-12-30","last_seen":"2023-01-20"}],"transactions":[{"id":8435676,"accession":"0001209191-23-004285","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-004285","line_url":"/filing/0001209191-23-004285#line-1","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1272.0,"shares_display":"1,272","price_per_share":26.89,"price_display":"26.89","price_state":"stated","total_value":34204.08,"total_display":"34,204.08","total_whole":"34,204","shares_owned_after":354303.0,"shares_owned_after_display":"354,303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-20","scope":"insider"},{"id":8069664,"accession":"0001209191-23-001951","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-001951","line_url":"/filing/0001209191-23-001951#line-1","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2779.0,"shares_display":"2,779","price_per_share":26.9,"price_display":"26.90","price_state":"stated","total_value":74755.1,"total_display":"74,755.10","total_whole":"74,755","shares_owned_after":355575.0,"shares_owned_after_display":"355,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-05","scope":"insider"},{"id":6374633,"accession":"0001209191-22-054195","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-054195","line_url":"/filing/0001209191-22-054195#line-1","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1933.0,"shares_display":"1,933","price_per_share":25.2,"price_display":"25.20","price_state":"stated","total_value":48711.6,"total_display":"48,711.60","total_whole":"48,712","shares_owned_after":358354.0,"shares_owned_after_display":"358,354","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-18","filed_date":"2022-10-20","scope":"insider"},{"id":6658212,"accession":"0001209191-22-052984","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-052984","line_url":"/filing/0001209191-22-052984#line-1","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3679.0,"shares_display":"3,679","price_per_share":24.4,"price_display":"24.40","price_state":"stated","total_value":89767.6,"total_display":"89,767.60","total_whole":"89,768","shares_owned_after":360287.0,"shares_owned_after_display":"360,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-06","scope":"insider"},{"id":6657645,"accession":"0001209191-22-046001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-046001","line_url":"/filing/0001209191-22-046001#line-2","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31214.0,"shares_display":"31,214","price_per_share":18.23,"price_display":"18.23","price_state":"stated","total_value":569031.22,"total_display":"569,031.22","total_whole":"569,031","shares_owned_after":363966.0,"shares_owned_after_display":"363,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-16","scope":"insider"},{"id":6330257,"accession":"0001209191-22-042694","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-042694","line_url":"/filing/0001209191-22-042694#line-1","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1935.0,"shares_display":"1,935","price_per_share":12.87,"price_display":"12.87","price_state":"stated","total_value":24903.45,"total_display":"24,903.45","total_whole":"24,903","shares_owned_after":270400.0,"shares_owned_after_display":"270,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-18","filed_date":"2022-07-20","scope":"insider"},{"id":6892688,"accession":"0001209191-22-041615","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-041615","line_url":"/filing/0001209191-22-041615#line-1","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3702.0,"shares_display":"3,702","price_per_share":13.4,"price_display":"13.40","price_state":"stated","total_value":49606.8,"total_display":"49,606.80","total_whole":"49,607","shares_owned_after":272335.0,"shares_owned_after_display":"272,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-06","filed_date":"2022-07-08","scope":"insider"},{"id":6509893,"accession":"0001209191-22-025174","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-025174","line_url":"/filing/0001209191-22-025174#line-1","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8002.0,"shares_display":"8,002","price_per_share":10.45,"price_display":"10.45","price_state":"stated","total_value":83620.9,"total_display":"83,620.90","total_whole":"83,621","shares_owned_after":276037.0,"shares_owned_after_display":"276,037","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-19","filed_date":"2022-04-21","scope":"insider"},{"id":6351514,"accession":"0001209191-22-023666","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-023666","line_url":"/filing/0001209191-22-023666#line-1","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2436.0,"shares_display":"2,436","price_per_share":13.78,"price_display":"13.78","price_state":"stated","total_value":33568.08,"total_display":"33,568.08","total_whole":"33,568","shares_owned_after":172928.0,"shares_owned_after_display":"172,928","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-05","filed_date":"2022-04-07","scope":"insider"},{"id":6888806,"accession":"0001209191-22-002202","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-002202","line_url":"/filing/0001209191-22-002202#line-1","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4475.0,"shares_display":"4,475","price_per_share":16.27,"price_display":"16.27","price_state":"stated","total_value":72808.25,"total_display":"72,808.25","total_whole":"72,808","shares_owned_after":175364.0,"shares_owned_after_display":"175,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-04","filed_date":"2022-01-06","scope":"insider"},{"id":5384580,"accession":"0001209191-21-059910","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-059910","line_url":"/filing/0001209191-21-059910#line-1","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6671.0,"shares_display":"6,671","price_per_share":21.62,"price_display":"21.62","price_state":"stated","total_value":144227.02,"total_display":"144,227.02","total_whole":"144,227","shares_owned_after":179839.0,"shares_owned_after_display":"179,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-05","filed_date":"2021-10-07","scope":"insider"},{"id":4894637,"accession":"0001209191-21-046492","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-046492","line_url":"/filing/0001209191-21-046492#line-1","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6954.0,"shares_display":"6,954","price_per_share":21.52,"price_display":"21.52","price_state":"stated","total_value":149650.08,"total_display":"149,650.08","total_whole":"149,650","shares_owned_after":186510.0,"shares_owned_after_display":"186,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-09","filed_date":"2021-07-13","scope":"insider"},{"id":5158344,"accession":"0001209191-21-026086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-026086","line_url":"/filing/0001209191-21-026086#line-1","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10862.0,"shares_display":"10,862","price_per_share":18.62,"price_display":"18.62","price_state":"stated","total_value":202250.44,"total_display":"202,250.44","total_whole":"202,250","shares_owned_after":135003.0,"shares_owned_after_display":"135,003","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-06","filed_date":"2021-04-08","scope":"insider"},{"id":4614664,"accession":"0001209191-21-021304","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-021304","line_url":"/filing/0001209191-21-021304#line-2","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":25.0671,"price_display":"25.07","price_state":"stated","total_value":752013.0,"total_display":"752,013.00","total_whole":"752,013","shares_owned_after":145865.0,"shares_owned_after_display":"145,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider"},{"id":2226786,"accession":"0001209191-20-064824","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-064824","line_url":"/filing/0001209191-20-064824","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":25.40541,"price_display":"25.41","price_state":"stated","total_value":254054.1,"total_display":"254,054.10","total_whole":"254,054","shares_owned_after":146165.0,"shares_owned_after_display":"146,165","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider","n_lines":2},{"id":2346692,"accession":"0001209191-20-062937","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-062937","line_url":"/filing/0001209191-20-062937#line-4","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19400.0,"shares_display":"19,400","price_per_share":25.195,"price_display":"25.20","price_state":"stated","total_value":488783.0,"total_display":"488,783.00","total_whole":"488,783","shares_owned_after":145865.0,"shares_owned_after_display":"145,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-10","filed_date":"2020-12-11","scope":"insider"},{"id":2346684,"accession":"0001209191-20-062937","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-062937","line_url":"/filing/0001209191-20-062937#line-2","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":25.0817,"price_display":"25.08","price_state":"stated","total_value":15049.02,"total_display":"15,049.02","total_whole":"15,049","shares_owned_after":145865.0,"shares_owned_after_display":"145,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-09","filed_date":"2020-12-11","scope":"insider"},{"id":3090917,"accession":"0001209191-20-049166","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-049166","line_url":"/filing/0001209191-20-049166#line-2","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26700.0,"shares_display":"26,700","price_per_share":20.048,"price_display":"20.05","price_state":"stated","total_value":535281.6,"total_display":"535,281.60","total_whole":"535,282","shares_owned_after":145865.0,"shares_owned_after_display":"145,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-31","filed_date":"2020-09-02","scope":"insider"},{"id":2145198,"accession":"0001209191-20-048673","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-048673","line_url":"/filing/0001209191-20-048673#line-4","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2600.0,"shares_display":"2,600","price_per_share":20.02,"price_display":"20.02","price_state":"stated","total_value":52052.0,"total_display":"52,052.00","total_whole":"52,052","shares_owned_after":145865.0,"shares_owned_after_display":"145,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-28","filed_date":"2020-08-28","scope":"insider"},{"id":2145190,"accession":"0001209191-20-048673","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-048673","line_url":"/filing/0001209191-20-048673#line-2","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":2000.0,"total_display":"2,000.00","total_whole":"2,000","shares_owned_after":145865.0,"shares_owned_after_display":"145,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-26","filed_date":"2020-08-28","scope":"insider"},{"id":3090756,"accession":"0001209191-20-047963","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-047963","line_url":"/filing/0001209191-20-047963#line-2","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":12000.0,"total_display":"12,000.00","total_whole":"12,000","shares_owned_after":145865.0,"shares_owned_after_display":"145,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-19","filed_date":"2020-08-21","scope":"insider"},{"id":8122105,"accession":"0001209191-19-062189","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-062189","line_url":"/filing/0001209191-19-062189#line-1","is_derivative":false,"issuer_cik":"0001679082","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001679082","owner_cik":"0001712069","owner_name":"Lang Matthew","owner_display_name":"Lang Matthew","owner_url":"/insider/0001712069","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19018.0,"shares_display":"19,018","price_per_share":15.55,"price_display":"15.55","price_state":"stated","total_value":295729.9,"total_display":"295,729.90","total_whole":"295,730","shares_owned_after":34597.0,"shares_owned_after_display":"34,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-30","filed_date":"2019-12-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001679082","name":"Myovant Sciences Ltd.","url":"/issuer/0001679082","role":"Officer (General Counsel & Corp. Secy)","n_filings":20,"first_seen":"2019-12-30","last_seen":"2023-01-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001712069","retrieved_at":"2026-08-23T06:14:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}